Patients with suspected keratoendotheliitis fugax hereditaria require a referral to an ophthalmologist familiar with the disease. Genetic counselors or geneticists should also be included as part of the healthcare team for these patients to provide information and resources to patients. Prescriptions of topical or oral medications may be of some benefit to these individuals. As newer immunologic inflammatory inhibitors become available as pharmaceutical options, the healthcare team should also include a pharmacist familiar with the pharmacokinetics of these drugs to help optimize outcomes. [Level 5]